1996
DOI: 10.1227/00006123-199606000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Treatment of Malignant Gliomas with Intramuscularly Administered Polyinosinic-Polycytidylic Acid Stabilized with Polylysine and Carboxymethylcellulose: An Open Pilot Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
51
0
3

Year Published

1999
1999
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 101 publications
(54 citation statements)
references
References 26 publications
0
51
0
3
Order By: Relevance
“…Clinical-grade TLR3 ligands are being considered as immunostimulatory and antiviral agents for in vivo applications (6,10,52,53). Early studies demonstrated promise for poly(I:C) treatment in reducing the viral burden in HIV-infected individuals (10,52).…”
Section: Discussionmentioning
confidence: 99%
“…Clinical-grade TLR3 ligands are being considered as immunostimulatory and antiviral agents for in vivo applications (6,10,52,53). Early studies demonstrated promise for poly(I:C) treatment in reducing the viral burden in HIV-infected individuals (10,52).…”
Section: Discussionmentioning
confidence: 99%
“…tested in a clinical trial for direct treatment of glioblastoma (29). Both IFN and poly(I:C) protected normal brain cells from recombinant VSVs.…”
Section: Discussionmentioning
confidence: 99%
“…We have addressed this issue using two strategies: the ®rst takes advantage of a VV recombinant that expresses PKR under regulation of the E. coli lacI operator/repressor system, the second is based on treating cells with a synthetic dsRNA polymer composed of alternating riboinosinic and ribocytidilic subunits (pIC), usually used as a model of viral infection or dsRNA-triggered processes. Characterizing this apoptosisinvolved pathway is of particular importance, since pIC is being used in dierent clinical trials for tumour treatments (Robinson et al, 1976;Salazar et al, 1996) and PKR has been invoked as a tumour suppresser gene (Meurs et al, 1993;Koromilas et al, 1992).…”
Section: Introductionmentioning
confidence: 99%